In this study, we firstly detected the influence of fluoxetine on astrocytic TXNIP level in depression, and observed that fluoxetine increased TXNIP-GLUT1 pathway-mediated glucose uptake in corticosterone-stimulated PFC astrocytes in vivo and in vitro. The gene discussed is TXNIP; the disease is depressive symptom measurement.